Tech Company Financing Transactions
Fountain Therapeutics Funding Round
On 11/19/2021, Fountain Therapeutics raised $15 million in Series A investment from Alexandria Venture Investments, Eli Lilly and Company and Khosla Ventures.
Transaction Overview
Company Name
Announced On
11/19/2021
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds from the financing will be used to expand Fountain's platform, pipeline and team as it enters its next phase of growth.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
681 Gateway Blvd. South
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Overview
At Fountain Therapeutics, we have combined the expertise of leaders in aging research and computation to build a pipeline of therapeutics aimed at reversing cellular aging. Our mission is to decouple aging from disease and significantly extend human health span. Our AI-driven platform extracts previously hidden cellular features to measure aging with remarkable precision.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Thomas Rando
Chief Executive Officer
John Dimos
Co-Founder
Thomas Cheung
Co-Founder
Joseph Rodgers
Browse more venture capital transactions:
Prev: 11/19/2021: Nexar venture capital transaction
Next: 11/19/2021: Ultraleap venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs